Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Bermingham Nessan
President & CEO at Intellia Therapeutics. Filing since 6 Dec 2017.
CIK 0001377759
Company
Date
Role
Action
Shares
Amount
Of holding
NTLA
Intellia Therapeutics, Inc.
8 Dec 2017
President & CEO
Sold, plan not stated
94,143
$1.96M
17.0%
NTLA
Intellia Therapeutics, Inc.
7 Dec 2017
President & CEO
Sold, plan not stated
131,140
$2.77M
19.2%
NTLA
Intellia Therapeutics, Inc.
6 Dec 2017
President & CEO
Sold, plan not stated
111,500
$2.27M
14.0%
3 decisions on file.
